Viewing Study NCT06659120


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-25 @ 4:17 AM
Study NCT ID: NCT06659120
Status: RECRUITING
Last Update Posted: 2024-10-26
First Post: 2024-08-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Sponsor: Insel Gruppe AG, University Hospital Bern
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module